The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with definitive 4-year (yr) disease-free survival (DFS) results.
 
Helena Margaret Earl
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo; Pfizer
Consulting or Advisory Role - AstraZeneca; Celgene; Pfizer; Roche
Research Funding - Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Daiichi Sankyo; Pfizer
 
Louise Hiller
No Relationships to Disclose
 
Anne-Laure Vallier
No Relationships to Disclose
 
Shrushma Loi
No Relationships to Disclose
 
Donna Howe
No Relationships to Disclose
 
Helen B Higgins
No Relationships to Disclose
 
Karen McAdam
Honoraria - Novartis; Roche
Consulting or Advisory Role - Roche
 
Luke Hughes-Davies
No Relationships to Disclose
 
Adrian Nigel Harnett
Speakers' Bureau - Genomic Health
 
Mei-Lin Ah-See
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca (I); Merck Sharp & Dohme (I); Novartis (I); Pierre Fabre (I)
 
Richard Simcock
Consulting or Advisory Role - Genomic Health; Novartis
 
Daniel William Rea
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Roche
Research Funding - AstraZeneca (Inst); PUMA NALA (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Janine Mansi
No Relationships to Disclose
 
Jean Abraham
Research Funding - AstraZeneca/MedImmune
 
Carlos Caldas
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); SERVIER (Inst)
 
Claire Hulme
No Relationships to Disclose
 
David Miles
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Andrew M. Wardley
Honoraria - AstraZeneca; Lilly; Novartis; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; MSD Oncology; Novartis; Pierre Fabre; Roche
Speakers' Bureau - AstraZeneca; Eisai; Novartis; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Roche
 
David A. Cameron
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis
 
Janet Dunn
No Relationships to Disclose